pared to 81.2% (75.3-86.1) in the separate analysis of unruptured GIA. For each year added to patient age, PGO decreased by 0.8%, both for all GIA and unruptured GIA. For all GIA, surgical treatment resulted in a PGO of 80.3% (95% CI 76.0-84.6) compared to 84.2% (78.5-89.8, p = 0.27) after endovascular treatment. In unruptured GIA, PGO was 79.7% (95% CI 71.5-87.8) after surgical treatment and 84.9% (79.1-90.7, p = 0.54) after endovascular treatment. PGO was lower in high quality studies and in studies presenting aggregate instead of individual patient data. In unruptured GIA, the OR for good treatment outcome was 5.2 (95% CI 2.0-13.0) at the internal carotid artery compared to 0.1 (0.1-0.3, p < 0.1) in the posterior circulation. Patient sex, FU-T and prevalence of ruptured GIA were not associated with PGO. Conclusions: We found that the chances of good outcome after surgical or endovascular GIA treatment mainly depend on patient age and aneurysm location rather than on the type of treatment conducted. Our analysis may inform future research on GIA.
Introduction
Increasing intracranial aneurysm (IA) size is one of the main risk factors for aneurysm rupture with subsequent morbidity and mortality [1] [2] [3] [4] [5] . Guidelines therefore recommend conservative treatment for unruptured small IA, with cutoffs ranging between 7 and 13 mm in diameter and surgical or endovascular treatment for larger aneurysms [2, 3, [6] [7] [8] . Surgical and endovascular treatment have become common for unruptured large IA and are also increasingly conducted in unruptured giant IA (GIA), which are defined as the largest IA with a diameter ≥ 25 mm and are known for rupture rates exceeding 10% per year [1, 9] . While the treatment of unruptured large IA is widely accepted, the treatment of unruptured GIA remains controversial due to reports on poor outcome and overall cost ineffectiveness [1, 10] .
Accurate estimates on surgical or endovascular GIA treatment outcome are difficult to establish mainly due to the low prevalence of the disease since GIA only make up about 2-5% of all IAs [1, 3] . Multicenter prospective approaches have so far only been able to examine GIA treatment outcome as a marginal byproduct of cohorts that predominantly contain data on non-giant IAs [1] .
Since GIA are associated with the worst outcome and the highest cost of all IAs, there is a need for robust scientific evidence exclusively focusing on this subgroup of IAs. We conducted a systematic review and meta-analysis of recent literature on surgical or endovascular GIA treatment outcome. The main aim was to examine GIA treatment outcome with emphasis on patient age, GIA location, the type of treatment and unruptured GIA.
Methods

Search Strategy and Selection Criteria
The analysis was designed according to the PRISMA statement [11] . We searched Medline and Embase for studies reporting on outcome of surgical or endovascular GIA treatment. The search was conducted on March 5, 2014 , and included studies published between January 2000 and present to reflect the current state of GIA therapy. We used the MeSH term 'intracranial aneurysm * ' with subheadings 'therapy', 'surgery', 'mortality' and 'disease management'. We added the following keywords: - [ The following inclusion criteria were defined. Publications had to be in English. Patients had to be at least 18 years old. If a study also included pediatric patients (<18 years), only data on adult patients were included. Treatment outcome had to be reported for at least 4 IA patients to avoid case reports of anecdotal character. Data on GIA had to be distinguishable from those on non-giant IA. Treatment outcome had to be reported either by using scoring systems such as modified Rankin score (mRS) or Glasgow outcome score (GOS) or by describing the patient's clinical status in sufficient detail for a clear interpretation. We also screened reference lists of included publications and the personal databases of the principal investigators (J.D. and P.V.). If uncertainties occurred regarding the type of data presentation, we contacted the authors and asked them to provide the data in a way that made inclusion possible. If relevant data, for example, treatment outcome or GIA location, were missing for a case, the entire case was excluded from the analysis. Principal reviewers were J.D. and N.M. They independently searched the literature and screened titles and abstracts. In case of disagreement, the details were discussed until an agreement was reached. Both reviewers then conducted a full text screening of all eligible articles.
Data Extraction
Standardized forms were used by both reviewers to extract the following data: name of study author, year of publication, type of study design, time frame in which the study was conducted, total number of patients, number of patients with GIA, patient age and sex, prevalence of ruptured GIA, GIA location, type of treatment, follow-up time (FU-T), number of cases lost to follow-up, type of outcome description (GOS, mRS or no score), number of cases with good or bad outcome and type of data presentation (aggregate or individual).
Study quality was assessed according to the following categories: outcome described by score (1 point) or neurological symptoms (0 points), study design prospective (1 point) or retrospective (0 points), cases lost to follow-up less than 3% (1 point) or more than 3% (0 points). Studies with 3 points were graded high quality, and studies with less than 3 points lower quality.
Good outcome was classified as GOS 4-5 or mRS 0-2 or improvement or no aggravation of clinical symptoms compared to pre-treatment status [12] . GIA location was categorized as internal carotid artery (ICA, including the posterior communicating artery), middle cerebral artery (MCA), anterior cerebral artery (ACA, including the anterior communicating artery) and posterior circulation (including the vertebral, basilar, cerebellar and posterior cerebral arteries). The type of treatment was divided into surgical, endovascular and combined surgical/endovascular. For quality control, a third reviewer (S.G.) also completed the data extraction form for 10 studies randomly selected from the pool of eligible studies.
Statistical Analysis
The primary end point was the proportion of good outcome (PGO) interpreted as probability value and displayed as percentage with corresponding 95% CI. The PGO was calculated as the number of GIA cases with good outcome divided by the total number of included GIA cases. Meta-analysis was conducted using a random effects model including a grand mean for PGO, the deviation of the study's true PGO from the grand mean and the deviation of the study's observed PGO from the study's true PGO (sampling error). Using this model, the mean PGO was estimated by a weighted mean over the single studies with assigned weights as inverse of the sum of within-study variance and estimated hetero-geneity variance. The variance of the distribution of the deviations of the study's true PGOs from the grand mean was denoted by τ 2 (heterogeneity variance), which was calculated using the DerSimonian method [13] . The heterogeneity of proportions was analyzed using a Q-statistic test, measuring weighted squared deviations. We used the I 2 -statistic to estimate the proportion of the observed variance in PGO. Sub-group meta-analyses were conducted for the following categories: patient age and sex, type of treatment, study quality, type of outcome description, mean FU-T (shorter than or equal to and longer than the median of all mean FU-Ts), prevalence of ruptured GIA (0, <33.3 or ≥ 33.3%) and type of patient data presentation (aggregate or individual). Meta-regression was conducted to explore the heterogeneity of PGO in more detail and adjust PGO by including mean age as covariate for 4 models using patient sex, type of treatment, prevalence of ruptured GIA and the type of patient data presentation as factors.
For the separate evaluation of individual patient data, we used univariate cross table analysis and subsequent hierarchical logistic regression analysis to examine the relationship between the odds for good outcome and the variables GIA location, patient age and type of treatment. Patient age was divided into 4 quartiles: <45, 45-54, 55-63, and >63 years. We used multilevel models with the covariates patient age and type of treatment to calculate adjusted OR for good outcome for each GIA location taking into account clustering of patients within different study populations. We applied a mixed effects model including the random study effect as a G-side effect.
Since outcome data for ruptured and unruptured GIA were not separable in all studies, we used 3 different approaches for data analysis. The first approach examined the PGO for the entire data stock by meta-analysis, including both ruptured and unruptured GIA. The second approach exclusively examined unruptured GIA presented as aggregate or individual patient data, again using meta-analysis. For this, we excluded all ruptured GIA cases from studies presenting individual patient data and all studies presenting aggregate patient data that did not differentiate between outcome data for ruptured and unruptured GIA. The third approach exclusively analyzed unruptured GIA presented as individual patient data applying hierarchical logistic regression within a multilevel model.
For statistical analysis, we used SAS 9.2 (SAS Institute Inc., Cary, N.C., USA) and OpenMeta[Analyst] for Windows 7 (Brown University, Providence, R.I., USA) [14] .
Results
The inclusion criteria were met by 54 studies with 64 study populations and 1,269 GIA ( fig. 1 ) [1, . Patient data description was aggregate in 15 study populations (854 GIA) [1, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] and individual in 49 study populations (415 GIA) . Table 1 ( fig. 2 ). There was a significant association between PGO and patient age (p < 0.01). For any year added to mean patient age, PGO decreased by 0.8%. This relationship existed in all 3 treatment groups. We adjusted all further analyses for patient age. Table 2 displays the PGO for the type of treatment, study quality, type of outcome description, FU-T, type of patient data description and prevalence of ruptured GIA.
With the surgical study populations as the reference group, there was no significant difference in PGO between surgical (80.3%, 95% CI 76.0-84.6) and endovascular study populations (84.2%, 95% CI 78.5-89.8, p = 0.27). The PGO for combined treatment study populations differed significantly (49.9%, 95% CI 28.4-71.5%, p = 0.01). However, the total number of patients with combined treatment was comparably low (n = 17).
When high quality study populations were defined as the reference group, their PGO (70.0%, 95% CI 60.9-79.2) was significantly lower than that of studies of lower quality (83.6%, 95% CI 77.7-90.0, p = 0.01). We also identified a significant difference in PGO depending on whether results were presented as aggregate patient data (75.3%, 95% CI 69.3-81.3) or as individual patient data (83.8, 95% CI 79.6-88.1, p < 0.01). PGO was not associated with patient sex, type of outcome description, FU-T or prevalence of ruptured GIA. We found substantial overall heterogeneity (I 2 = 48%) in the analysis of PGO, which suggests relevant differences in study populations. For the separate analysis of treatment outcome of unruptured GIA, we included 455 unruptured GIA from 51 study populations [1, 22, , presented as aggregate patient data in 3 study populations (128 GIA) [1, 22] and as individual patient data in 48 study populations (327 GIA) . Endovascular treatment was conducted in 26 study populations (246 GIA) [1, 27-31, 33-35, 38, 41-47, 52, 55, 56, 58, 61, 63, 65-67] , surgical treatment in 20 study populations (196 GIA) [1, 22, 32, 36, 37, 39, 40, 45, 48-54, 57, 59, 60, 62, 64] and combined treatment in 5 study populations (13 GIA) [32, 45, 51, 60, 63] . For all unruptured GIA taken together, the PGO was 81.2% (95% CI 75.3-86.1). Patient age was significantly associated with PGO, which decreased by 0.8% per year added to patient age (p = 0.01). Table 2 displays the PGO for unruptured GIA. After adjusting for patient age, we identified no difference in PGO between surgical (79.7%, 95% CI 71.5-87.8, reference group) and endovascular study populations (84.9%, 95% CI 79.1-90.7, p = 0.54). For the small group of unruptured GIA with combined treatment (13 GIA), PGO was significantly lower (50.3%, 95% CI 25.6-75.0, p = 0.02). High quality study populations displayed lower PGO (68.1%, 95% CI 58.7-77.4) than study populations of lower quality (84.3%, 95% CI 76.5-92.8, p = 0 · 01). We also found lower PGO in study populations with aggregate patient data (62.5%, 95% CI 54.2-70.9) than in study populations with individual patient data (84.1%, 95% CI 79.7-88.7, p < 0.01). There was no association between PGO and patient sex, type of outcome description or FU-T.
To examine the PGO of unruptured GIA in more detail, we conducted an analysis of only individual patient data on unruptured GIA. For this, we included 324 unruptured GIA from 48 study populations . Treatment was endovascular in 192 GIA (25 study populations) [27-31, 33-35, 38, 41-47, 52, 55, 56, 58, 61, 63, 65-67] , surgical in 119 GIA (18 study populations) [32, 36, 37, 39, 40, 45, 48-54, 57, 59, 60, 62, 64] and combined in 13 GIA (5 study populations) [32, 45, 51, 60, 63, 64] . We included 324 GIA from 48 study populations in this analysis . PGO is given as mean %. OR are presented with 95% CI and p value. PcomA = Posterior communicating artery; ref. 194 displays the PGO and OR for good outcome for the type of GIA treatment, GIA location and patient age. Both PGO and OR for good outcome were significantly lower for unruptured GIA in the posterior circulation than for those of all other locations (p < 0.01). Again, we found an association between patient age and PGO (p = 0.03). After adjusting for patient age and the location of unruptured GIA, there was no difference in PGO between surgical (80.7%, 95% CI 72.9-89.3, reference group), endovascular (84.4%, 95% CI 78.6-90.1) or combined treatment study populations (53.8%, 95% CI 22.5-75.0, p = 0.16). To establish OR for good treatment outcome for all locations of unruptured GIA rather than using the ICA as the reference group, we repeated the same model with all other locations of unruptured GIA as the reference group ( table 4 ).
Discussion
Our systematic review and meta-analysis found that the chances of good outcome after surgical or endovascular GIA treatment mainly depend on patient age and GIA location rather than on the type of treatment conducted. Overall PGO ranged above 80%, both for endovascular and surgical study populations. The chances of good outcome following endovascular or surgical GIA treatment decreased with increasing patient age in all GIA and in the subgroup of unruptured GIA. Unruptured GIA of the ICA were more likely to show good treatment outcome than unruptured GIA in the posterior circulation. These findings are in line with data on unruptured non-giant IA [1] .
Furthermore, we found that GIA treatment outcome was not influenced by patient sex, the time of follow-up or whether the patients' clinical status was presented based on scores or not. Also, there was no association between pre-treatment aneurysm rupture and GIA treatment outcome. This contradicts findings on non-giant IA [4] . A possible explanation may be that our analysis only included those ruptured GIA that underwent either endovascular or surgical treatment. This means that there are no data on patients with a ruptured GIA that were in too poor of a clinical condition to receive any sort of treatment. It is therefore highly likely that the subgroup of ruptured GIA in our analysis is selected for those patients in relatively good neurological condition and, therefore, may not represent the full spectrum of patients with ruptured GIA.
Our analysis also included a small cohort of unruptured GIA with combined surgical/endovascular treatment (n = 13). In this group, treatment outcome was significantly worse. However, these results have to be discussed with caution due to this group's comparably limited case number. Nevertheless, lower chances of good outcome after combined GIA treatment may also indicate that those cases were more complex and that the initial treatment, be it surgical or endovascular, may not have been successful or may have produced complications making a second type of intervention necessary.
GIA treatment outcome was also influenced by certain study characteristics, such as the type of data presentation and study quality. In studies presenting individual patient data, treatment outcome was significantly better than in studies presenting aggregate patient data. This disparity was more pronounced in the analysis of unruptured GIA. Furthermore, studies of lower quality reported significantly better treatment outcome than high quality studies. Since the majority of studies in our analysis was of lower quality, our overall findings may be biased toward a better treatment outcome. This becomes especially evident when comparing our overall results to those of the International Study of Unruptured Intracranial Aneurysms (ISUIA), which is the largest prospective study presenting data on unruptured GIA treatment outcome [1] . We were able to include recently updated ISUIA data after a mean FU-T of 10 years. ISUIA reached a good treatment outcome in 64.7% of GIA after endovascular and 61.6% of GIA after surgical treatment. Apart from ISUIA's relatively high study quality another potential explanation for ISUIA's outcome results ranging below our overall results may be our analysis' shorter mean FU-T of 16 months. In this sub-analysis of unruptured GIA with individually described patient data we included 324 GIA from 48 study populations . Data are presented with 95% CI and p value. PcomA = Posterior communicating artery. Our analysis is the first to systematically evaluate the current interdisciplinary GIA literature. Nevertheless, it has limitations. The quality of the included studies was predominantly low as all of them were purely observational and non-randomized. Only few studies were of prospective design [1, 19, 27, 39, 44, 57] . Study designdependent selection bias can therefore not be ruled out. Furthermore, there was substantial variance and heterogeneity in the included studies, which also suggests that our results should be discussed with caution. Additionally, since studies reporting better outcome were shown to be more likely to be published, some publication bias may also confound our overall results [68] . Another limitation is that we allowed different modes of outcome measurement. Even though we found that treatment outcome did not differ between score-based and non-score-based outcome quantification, we cannot exclude that the type of outcome description may have influenced our results. Finally, as all meta-analyses are limited by their search terms, so is ours. Our metaanalysis could have applied more specific search terms describing both surgical and endovascular techniques of treatment.
Conclusions
In light of the dismal natural history of unruptured GIA, the results of our analysis may help elucidate the controversial field of endovascular and surgical GIA treatment and may therefore be of interest for the ongoing discussion on how to treat unruptured GIA. Our findings support the view that when deciding which type of GIA treatment to conduct each case should be discussed interdisciplinarily with special focus on patient age and GIA location. Since our analysis showed that high quality clinical trial evidence on GIA treatment outcome is lacking, we feel that there is a need for a systematic multicenter approach to collect not only clinical but also imaging data on GIA. As a first step toward this goal, the currently ongoing GIA registry was established as an international prospective and retrospective observational trial aiming to serve as a platform for future GIA research [69] [70] [71] .
